Fatty Liver

Metabolite Betaine Improves Liver Status In Nonalcoholic Steatohepatitis

Published in Hepatitis Weekly, November 12th, 2001

by Sonia Nichols, senior medical writer - Betaine, a byproduct of choline metabolism, improves liver function and pathology in patients with nonalcoholic steatohepatitis (NASH), or fatty liver.

This disease, mostly affecting women and especially the obese, is characterized by excessive fat deposits within the liver cells. Based on a preliminary study, Mayo Clinic researchers in Rochester, Minnesota, say betaine (Cystadane) improves liver status in some people with NASH.

According to M.F. Abdelmalek and colleagues, 10 patients with NASH were prescribed twice-daily oral doses of Cystadane for 12 months, with 7 of the patients completing the full...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2001-11-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry